Market Analysis
In-depth Analysis of MEA Critical Care Equipment Market Industry Landscape
The global medical ventilator market is home to prominent players, including Becton, Dickinson and Company, Koninklijke Philips N.V., GE Healthcare, Smiths Group PLC, ResMed Inc., and Vyaire Medical, among others. Beyond these industry giants, other companies are actively engaging in partnerships with smaller entities, investing in innovative technologies, and introducing new medical ventilators to the market. In April 2020, Royal Philips collaborated with the US Government to bolster the production of hospital ventilators at its US manufacturing sites. The company aimed to double its production by May 2020 and successfully achieved a four-fold increase by the third quarter of 2020, meeting the growing demand for medical ventilators in the US and global markets.
Similarly, in May 2020, Vyaire Medical and Spirit Aerosystems joined forces to manufacture critical care ventilators, responding to the urgent needs arising from the COVID-19 pandemic.
Further strategic moves include Vyaire Medical's acquisitions in April 2018, where it acquired Acutronic, a developer of neonatal ventilation equipment, and IMT Medical, a mechanical ventilation device provider. These acquisitions, both based in Europe, demonstrated Vyaire Medical's commitment to expanding its capabilities and offerings.
In March 2020, a notable collaboration emerged when Ford and GE Healthcare licensed a ventilator design from Airon Corporation. The companies planned to produce 50,000 ventilators at a Michigan facility by July, contributing to the broader initiative to address the critical medical needs of COVID-19 patients.
Major industry players have recognized the potential for collaboration with innovative smaller entities to enhance the commercialization of their products.
The escalating demand for non-invasive medical ventilation systems is a key driver in the market. These ventilators offer advantages such as faster recovery times, shorter hospital stays, and the elimination of endotracheal tube usage. This makes them suitable for treating both acute and chronic respiratory failure. The increasing adoption of non-invasive ventilators for conditions like chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and acute respiratory disease is expected to fuel substantial growth in the medical ventilator market. This trend not only meets the evolving healthcare needs but also opens up opportunities for manufacturers and emerging players in the market. As the market continues to evolve, these advancements in medical ventilator technology are likely to play a crucial role in shaping the industry landscape.
Leave a Comment